1. Academic Validation
  2. The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes

The methyltransferase METTL9 mediates pervasive 1-methylhistidine modification in mammalian proteomes

  • Nat Commun. 2021 Feb 9;12(1):891. doi: 10.1038/s41467-020-20670-7.
Erna Davydova # 1 Tadahiro Shimazu # 2 Maren Kirstin Schuhmacher 3 Magnus E Jakobsson 4 5 Hanneke L D M Willemen 6 Tongri Liu 7 Anders Moen 1 Angela Y Y Ho 1 Jędrzej Małecki 1 Lisa Schroer 1 Rita Pinto 1 8 Takehiro Suzuki 9 Ida A Grønsberg 1 Yoshihiro Sohtome 10 11 Mai Akakabe 10 Sara Weirich 3 Masaki Kikuchi 12 Jesper V Olsen 4 Naoshi Dohmae 9 Takashi Umehara 12 Mikiko Sodeoka 10 11 Valentina Siino 5 Michael A McDonough 7 Niels Eijkelkamp 6 Christopher J Schofield 7 Albert Jeltsch 13 Yoichi Shinkai 14 Pål Ø Falnes 15
Affiliations

Affiliations

  • 1 Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway.
  • 2 Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • 3 Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany.
  • 4 Proteomics Program, Faculty of Health and Medical Sciences, Novo Nordisk Foundation Center for Protein Research (NNF-CPR), University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
  • 5 Department of Immunotechnology, Lund University, Medicon Village, 22100, Lund, Sweden.
  • 6 Center for Translational Immunology (CTI), University Medical Center Utrecht, Utrecht University, 3584, Utrecht, EA, The Netherlands.
  • 7 Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, UK.
  • 8 Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • 9 Biomolecular Characterization Unit, Technology Platform Division, RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • 10 Synthetic Organic Chemistry Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan.
  • 11 RIKEN Center for Sustainable Resource Science, Wako, Saitama, Japan.
  • 12 Laboratory for Epigenetics Drug Discovery, RIKEN Center for Biosystems Dynamics Research, Yokohama, Japan.
  • 13 Department of Biochemistry, Institute of Biochemistry and Technical Biochemistry, University of Stuttgart, Allmandring 31, 70569, Stuttgart, Germany. albert.jeltsch@ibtb.uni-stuttgart.de.
  • 14 Cellular Memory Laboratory, RIKEN Cluster for Pioneering Research, Wako, Saitama, Japan. yshinkai@riken.jp.
  • 15 Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316, Oslo, Norway. pal.falnes@ibv.uio.no.
  • # Contributed equally.
Abstract

Post-translational methylation plays a crucial role in regulating and optimizing protein function. Protein histidine methylation, occurring as the two isomers 1- and 3-methylhistidine (1MH and 3MH), was first reported five decades ago, but remains largely unexplored. Here we report that METTL9 is a broad-specificity methyltransferase that mediates the formation of the majority of 1MH present in mouse and human proteomes. METTL9-catalyzed methylation requires a His-x-His (HxH) motif, where "x" is preferably a small amino acid, allowing METTL9 to methylate a number of HxH-containing proteins, including the immunomodulatory protein S100A9 and the NDUFB3 subunit of mitochondrial respiratory Complex I. Notably, METTL9-mediated methylation enhances respiration via Complex I, and the presence of 1MH in an HxH-containing peptide reduced its zinc binding affinity. Our results establish METTL9-mediated 1MH as a pervasive protein modification, thus setting the stage for further functional studies on protein histidine methylation.

Figures